Free Trial

Turnstone Biologics (TSBX) Institutional Ownership

Turnstone Biologics logo
$0.47 +0.01 (+2.54%)
(As of 10:28 AM ET)

Institutional Ownership Changes (13F Filings) for Turnstone Biologics (NASDAQ:TSBX)

Current
Institutional Ownership
Percentage
52.51%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$536.05K
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$2.62M
Get TSBX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Turnstone Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TSBX Institutional Buying and Selling by Quarter

Turnstone Biologics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2024 Point72 Asset Management L.P.932,226$519K0.0%-16.7%4.030%
11/13/2024 FMR LLC1,172,987$653K0.0%+3.3%5.071%
8/19/2024 Point72 Asset Management L.P.1,118,588$2.93M0.0%-5.5%4.837%
8/13/2024 Sei Investments Co.11,882$31K0.0%N/A0.051%
5/17/2024 Zimmer Partners LP179,026$469K0.0%+271.4%0.774%
4/17/2024 Kathleen S. Wright Associates Inc.42,553$111K0.1%N/A0.184%
2/15/2024 PFM Health Sciences LP633,313$1.61M0.1%-58.5%2.742%
2/15/2024 Caas Capital Management LP45,831$117K0.0%-40.1%0.198%
12/6/2023 Citigroup Inc.7,524$30K0.0%N/A0.033%
11/15/2023 Sectoral Asset Management Inc.517,648$2.04M0.4%N/A2.266%
11/14/2023 Eventide Asset Management LLC708,317$2.79M0.1%N/A3.101%
11/13/2023 FMR LLC2,830,284$11.15M0.0%N/A12.392%
11/7/2023 New York State Common Retirement Fund18,867$74K0.0%N/A0.083%
(Data available from 1/1/2016 forward)

TSBX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TSBX shares?

During the previous two years, 11 institutional investors and hedge funds held shares of Turnstone Biologics. The most heavily invested institutionals were Eventide Asset Management LLC ($2.79M), Sectoral Asset Management Inc. ($2.04M), PFM Health Sciences LP ($1.61M), FMR LLC ($653K), Point72 Asset Management L.P. ($519K), Zimmer Partners LP ($469K), and Caas Capital Management LP ($117K).Learn more on TSBX's institutional investors.

What percentage of Turnstone Biologics stock is owned by institutional investors?

52.51% of Turnstone Biologics stock is owned by institutional investors. Learn more on TSBX's institutional investor holdings.

Which institutional investors have been buying Turnstone Biologics stock?

The following institutional investors have purchased Turnstone Biologics stock in the last 24 months: FMR LLC ($2.87M), Eventide Asset Management LLC ($708.32K), Sectoral Asset Management Inc. ($517.65K), Zimmer Partners LP ($130.83K), Kathleen S. Wright Associates Inc. ($42.55K), New York State Common Retirement Fund ($18.87K), and Sei Investments Co. ($11.88K).

How much institutional buying is happening at Turnstone Biologics?

Institutional investors have bought a total of 4,305,639 shares in the last 24 months. This purchase volume represents approximately $16.59M in transactions.

Which Turnstone Biologics major shareholders have been selling company stock?

The following institutional investors have sold Turnstone Biologics stock in the last 24 months: PFM Health Sciences LP ($891.40K), Point72 Asset Management L.P. ($251.66K), and Caas Capital Management LP ($30.68K).

How much institutional selling is happening at Turnstone Biologics?

Institutional investors have sold a total of 1,173,736 shares in the last 24 months. This volume of shares sold represents approximately $2.62M in transactions.



This page (NASDAQ:TSBX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners